Industry Research Reports
Home > Reports > Chemical & Material > Global Acitretin Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Acitretin Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-21
Pages: 136 Pages
Report ld: 5191958
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Acitretin market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
From a downstream perspective, Psoriasis accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Acitretin leading manufacturers including Biophore, Solara, Sun Pharma, HuaPont Pharm, USV, Olon, ChemPacific, etc., dominate supply; the top five capture approximately % of global revenue, with Biophore leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Acitretin market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Biophore
- Solara
- Sun Pharma
- HuaPont Pharm
- USV
- Olon
- ChemPacific
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- DMF
- GMP
- CEP
Segment by Application
- Psoriasis
- Keratoderma
- Others
CHAPTER OUTLINE
Chapter 1: Defines the Acitretin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Acitretin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Acitretin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 DMF
1.2.3 GMP
1.2.4 CEP
1.3 Market Segmentation by Application
1.3.1 Global Acitretin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Psoriasis
1.3.3 Keratoderma
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Acitretin Revenue Estimates and Forecasts 2020-2031
2.2 Global Acitretin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Acitretin Sales Estimates and Forecasts 2020-2031
2.4 Global Acitretin Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Acitretin Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Acitretin Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Acitretin Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 DMF Market Size by Manufacturers
4.5.2 GMP Market Size by Manufacturers
4.5.3 CEP Market Size by Manufacturers
4.6 Global Acitretin Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Acitretin Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Acitretin Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Acitretin Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Acitretin Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Acitretin Sales and Revenue by Type (2020-2031)
7.4 North America Acitretin Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Acitretin Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Acitretin Sales and Revenue by Type (2020-2031)
8.4 Europe Acitretin Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Acitretin Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Acitretin Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Acitretin Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Acitretin Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Acitretin Sales and Revenue by Type (2020-2031)
10.4 Central and South America Acitretin Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Acitretin Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Acitretin Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Acitretin Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Acitretin Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Biophore
12.1.1 Biophore Corporation Information
12.1.2 Biophore Business Overview
12.1.3 Biophore Acitretin Product Models, Descriptions and Specifications
12.1.4 Biophore Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Biophore Acitretin Sales by Product in 2024
12.1.6 Biophore Acitretin Sales by Application in 2024
12.1.7 Biophore Acitretin Sales by Geographic Area in 2024
12.1.8 Biophore Acitretin SWOT Analysis
12.1.9 Biophore Recent Developments
12.2 Solara
12.2.1 Solara Corporation Information
12.2.2 Solara Business Overview
12.2.3 Solara Acitretin Product Models, Descriptions and Specifications
12.2.4 Solara Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Solara Acitretin Sales by Product in 2024
12.2.6 Solara Acitretin Sales by Application in 2024
12.2.7 Solara Acitretin Sales by Geographic Area in 2024
12.2.8 Solara Acitretin SWOT Analysis
12.2.9 Solara Recent Developments
12.3 Sun Pharma
12.3.1 Sun Pharma Corporation Information
12.3.2 Sun Pharma Business Overview
12.3.3 Sun Pharma Acitretin Product Models, Descriptions and Specifications
12.3.4 Sun Pharma Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Sun Pharma Acitretin Sales by Product in 2024
12.3.6 Sun Pharma Acitretin Sales by Application in 2024
12.3.7 Sun Pharma Acitretin Sales by Geographic Area in 2024
12.3.8 Sun Pharma Acitretin SWOT Analysis
12.3.9 Sun Pharma Recent Developments
12.4 HuaPont Pharm
12.4.1 HuaPont Pharm Corporation Information
12.4.2 HuaPont Pharm Business Overview
12.4.3 HuaPont Pharm Acitretin Product Models, Descriptions and Specifications
12.4.4 HuaPont Pharm Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 HuaPont Pharm Acitretin Sales by Product in 2024
12.4.6 HuaPont Pharm Acitretin Sales by Application in 2024
12.4.7 HuaPont Pharm Acitretin Sales by Geographic Area in 2024
12.4.8 HuaPont Pharm Acitretin SWOT Analysis
12.4.9 HuaPont Pharm Recent Developments
12.5 USV
12.5.1 USV Corporation Information
12.5.2 USV Business Overview
12.5.3 USV Acitretin Product Models, Descriptions and Specifications
12.5.4 USV Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 USV Acitretin Sales by Product in 2024
12.5.6 USV Acitretin Sales by Application in 2024
12.5.7 USV Acitretin Sales by Geographic Area in 2024
12.5.8 USV Acitretin SWOT Analysis
12.5.9 USV Recent Developments
12.6 Olon
12.6.1 Olon Corporation Information
12.6.2 Olon Business Overview
12.6.3 Olon Acitretin Product Models, Descriptions and Specifications
12.6.4 Olon Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Olon Recent Developments
12.7 ChemPacific
12.7.1 ChemPacific Corporation Information
12.7.2 ChemPacific Business Overview
12.7.3 ChemPacific Acitretin Product Models, Descriptions and Specifications
12.7.4 ChemPacific Acitretin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 ChemPacific Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Acitretin Industry Chain
13.2 Acitretin Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Acitretin Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Acitretin Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Acitretin Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Acitretin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Acitretin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Acitretin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Acitretin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Acitretin Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Acitretin Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Acitretin Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 7. Global Acitretin Sales by Region (2020-2025) & (Tons)
Table 8. Global Acitretin Sales by Region (2026-2031) & (Tons)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Acitretin Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
Table 11. Global Acitretin Production by Region (2020-2025) & (Tons)
Table 12. Global Acitretin Production by Region (2026-2031) & (Tons)
Table 13. Global Acitretin Sales by Manufacturers (2020-2025) & (Tons)
Table 14. Global Acitretin Sales Share by Manufacturers (2020-2025)
Table 15. Global Acitretin Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Acitretin Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Acitretin by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acitretin as of 2024)
Table 19. Global Acitretin Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Acitretin Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Ton)
Table 21. Key Manufacturers Acitretin Manufacturing Base and Headquarters
Table 22. Global Acitretin Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Acitretin Sales by Type (2020-2025) & (Tons)
Table 26. Global Acitretin Sales by Type (2026-2031) & (Tons)
Table 27. Global Acitretin Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Acitretin Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Acitretin ASP by Type (2020-2031) & (US$/Ton)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Acitretin Sales by Application (2020-2025) & (Tons)
Table 32. Global Acitretin Sales by Application (2026-2031) & (Tons)
Table 33. Acitretin High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Acitretin Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Acitretin Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Acitretin ASP by Application (2020-2031) & (US$/Ton)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Acitretin Growth Accelerators and Market Barriers
Table 40. North America Acitretin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Acitretin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Acitretin Growth Accelerators and Market Barriers
Table 43. Europe Acitretin Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Acitretin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Acitretin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Acitretin Sales (Tons) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Acitretin Growth Accelerators and Market Barriers
Table 48. Southeast Asia Acitretin Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Acitretin Investment Opportunities and Key Challenges
Table 50. Central and South America Acitretin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Acitretin Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Acitretin Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Biophore Corporation Information
Table 54. Biophore Description and Major Businesses
Table 55. Biophore Product Models, Descriptions and Specifications
Table 56. Biophore Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 57. Biophore Sales Value Proportion by Product in 2024
Table 58. Biophore Sales Value Proportion by Application in 2024
Table 59. Biophore Sales Value Proportion by Geographic Area in 2024
Table 60. Biophore Acitretin SWOT Analysis
Table 61. Biophore Recent Developments
Table 62. Solara Corporation Information
Table 63. Solara Description and Major Businesses
Table 64. Solara Product Models, Descriptions and Specifications
Table 65. Solara Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 66. Solara Sales Value Proportion by Product in 2024
Table 67. Solara Sales Value Proportion by Application in 2024
Table 68. Solara Sales Value Proportion by Geographic Area in 2024
Table 69. Solara Acitretin SWOT Analysis
Table 70. Solara Recent Developments
Table 71. Sun Pharma Corporation Information
Table 72. Sun Pharma Description and Major Businesses
Table 73. Sun Pharma Product Models, Descriptions and Specifications
Table 74. Sun Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 75. Sun Pharma Sales Value Proportion by Product in 2024
Table 76. Sun Pharma Sales Value Proportion by Application in 2024
Table 77. Sun Pharma Sales Value Proportion by Geographic Area in 2024
Table 78. Sun Pharma Acitretin SWOT Analysis
Table 79. Sun Pharma Recent Developments
Table 80. HuaPont Pharm Corporation Information
Table 81. HuaPont Pharm Description and Major Businesses
Table 82. HuaPont Pharm Product Models, Descriptions and Specifications
Table 83. HuaPont Pharm Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 84. HuaPont Pharm Sales Value Proportion by Product in 2024
Table 85. HuaPont Pharm Sales Value Proportion by Application in 2024
Table 86. HuaPont Pharm Sales Value Proportion by Geographic Area in 2024
Table 87. HuaPont Pharm Acitretin SWOT Analysis
Table 88. HuaPont Pharm Recent Developments
Table 89. USV Corporation Information
Table 90. USV Description and Major Businesses
Table 91. USV Product Models, Descriptions and Specifications
Table 92. USV Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. USV Sales Value Proportion by Product in 2024
Table 94. USV Sales Value Proportion by Application in 2024
Table 95. USV Sales Value Proportion by Geographic Area in 2024
Table 96. USV Acitretin SWOT Analysis
Table 97. USV Recent Developments
Table 98. Olon Corporation Information
Table 99. Olon Description and Major Businesses
Table 100. Olon Product Models, Descriptions and Specifications
Table 101. Olon Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 102. Olon Recent Developments
Table 103. ChemPacific Corporation Information
Table 104. ChemPacific Description and Major Businesses
Table 105. ChemPacific Product Models, Descriptions and Specifications
Table 106. ChemPacific Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 107. ChemPacific Recent Developments
Table 108. Key Raw Materials Distribution
Table 109. Raw Materials Key Suppliers
Table 110. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 111. Milestones in Production Technology Evolution
Table 112. Distributors List
Table 113. Market Trends and Market Evolution
Table 114. Market Drivers and Opportunities
Table 115. Market Challenges, Risks, and Restraints
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Acitretin Product Picture
Figure 2. Global Acitretin Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. DMF Product Picture
Figure 4. GMP Product Picture
Figure 5. CEP Product Picture
Figure 6. Global Acitretin Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Psoriasis
Figure 8. Keratoderma
Figure 9. Others
Figure 10. Acitretin Report Years Considered
Figure 11. Global Acitretin Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Acitretin Revenue (2020-2031) & (US$ Million)
Figure 13. Global Acitretin Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Acitretin Revenue Market Share by Region (2020-2031)
Figure 15. Global Acitretin Sales (2020-2031) & (Tons)
Figure 16. Global Acitretin Sales (CAGR) by Region (2020-2031) (Tons)
Figure 17. Global Acitretin Sales Market Share by Region (2020-2031)
Figure 18. Global Acitretin Capacity, Production and Utilization (2020-2031) & (Tons)
Figure 19. Global Acitretin Production Trend by Region (2020-2031) (Tons)
Figure 20. Global Acitretin Production Market Share by Region (2020-2031)
Figure 21. Production Capacity Enablers & Constraints
Figure 22. Acitretin Production Growth Rate in North America (2020-2031) & (Tons)
Figure 23. Acitretin Production Growth Rate in Europe (2020-2031) & (Tons)
Figure 24. Acitretin Production Growth Rate in China (2020-2031) & (Tons)
Figure 25. Acitretin Production Growth Rate in Japan (2020-2031) & (Tons)
Figure 26. Top 5 and Top 10 Manufacturers Acitretin Sales Volume Market Share in 2024
Figure 27. Global Acitretin Revenue Market Share Ranking (2024)
Figure 28. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 29. DMF Revenue Market Share by Manufacturer in 2024
Figure 30. GMP Revenue Market Share by Manufacturer in 2024
Figure 31. CEP Revenue Market Share by Manufacturer in 2024
Figure 32. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 33. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 34. Global Acitretin Sales Market Share by Type (2020-2031)
Figure 35. Global Acitretin Revenue Market Share by Type (2020-2031)
Figure 36. Global Acitretin Sales Market Share by Application (2020-2031)
Figure 37. Global Acitretin Revenue Market Share by Application (2020-2031)
Figure 38. North America Acitretin Sales YoY (2020-2031) & (Tons)
Figure 39. North America Acitretin Revenue YoY (2020-2031) & (US$ Million)
Figure 40. North America Top 5 Manufacturers Acitretin Sales Revenue (US$ Million) in 2024
Figure 41. North America Acitretin Sales Volume (Tons) by Type (2020- 2031)
Figure 42. North America Acitretin Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 43. North America Acitretin Sales Volume (Tons) by Application (2020-2031)
Figure 44. North America Acitretin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. US Acitretin Revenue (2020-2031) & (US$ Million)
Figure 46. Canada Acitretin Revenue (2020-2031) & (US$ Million)
Figure 47. Mexico Acitretin Revenue (2020-2031) & (US$ Million)
Figure 48. Europe Acitretin Sales YoY (2020-2031) & (Tons)
Figure 49. Europe Acitretin Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Europe Top 5 Manufacturers Acitretin Sales Revenue (US$ Million) in 2024
Figure 51. Europe Acitretin Sales Volume (Tons) by Type (2020-2031)
Figure 52. Europe Acitretin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 53. Europe Acitretin Sales Volume (Tons) by Application (2020-2031)
Figure 54. Europe Acitretin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Germany Acitretin Revenue (2020-2031) & (US$ Million)
Figure 56. France Acitretin Revenue (2020-2031) & (US$ Million)
Figure 57. U.K. Acitretin Revenue (2020-2031) & (US$ Million)
Figure 58. Italy Acitretin Revenue (2020-2031) & (US$ Million)
Figure 59. Russia Acitretin Revenue (2020-2031) & (US$ Million)
Figure 60. Asia-Pacific Acitretin Sales YoY (2020-2031) & (Tons)
Figure 61. Asia-Pacific Acitretin Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Asia-Pacific Top 8 Manufacturers Acitretin Sales Revenue (US$ Million) in 2024
Figure 63. Asia-Pacific Acitretin Sales Volume (Tons) by Type (2020- 2031)
Figure 64. Asia-Pacific Acitretin Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 65. Asia-Pacific Acitretin Sales Volume (Tons) by Application (2020-2031)
Figure 66. Asia-Pacific Acitretin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Indonesia Acitretin Revenue (2020-2031) & (US$ Million)
Figure 68. Japan Acitretin Revenue (2020-2031) & (US$ Million)
Figure 69. South Korea Acitretin Revenue (2020-2031) & (US$ Million)
Figure 70. China Taiwan Acitretin Revenue (2020-2031) & (US$ Million)
Figure 71. India Acitretin Revenue (2020-2031) & (US$ Million)
Figure 72. Central and South America Acitretin Sales YoY (2020-2031) & (Tons)
Figure 73. Central and South America Acitretin Revenue YoY (2020-2031) & (US$ Million)
Figure 74. Central and South America Top 5 Manufacturers Acitretin Sales Revenue (US$ Million) in 2024
Figure 75. Central and South America Acitretin Sales Volume (Tons) by Type (2021-2031)
Figure 76. Central and South America Acitretin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 77. Central and South America Acitretin Sales Volume (Tons) by Application (2020-2031)
Figure 78. Central and South America Acitretin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 79. Brazil Acitretin Revenue (2020-2025) & (US$ Million)
Figure 80. Argentina Acitretin Revenue (2020-2025) & (US$ Million)
Figure 81. Middle East, and Africa Acitretin Sales YoY (2020-2031) & (Tons)
Figure 82. Middle East and Africa Acitretin Revenue YoY (2020-2031) & (US$ Million)
Figure 83. Middle East and Africa Top 5 Manufacturers Acitretin Sales Revenue (US$ Million) in 2024
Figure 84. Middle East and Africa Acitretin Sales Volume (Tons) by Type (2021-2031)
Figure 85. South America Acitretin Sales Revenue (US$ Million) by Type (2020-2031)
Figure 86. Middle East and Africa Acitretin Sales Volume (Tons) by Application (2020-2031)
Figure 87. Middle East and Africa Acitretin Sales Revenue (US$ Million) by Application (2020-2031)
Figure 88. GCC Countries Acitretin Revenue (2020-2025) & (US$ Million)
Figure 89. Turkey Acitretin Revenue (2020-2025) & (US$ Million)
Figure 90. Egypt Acitretin Revenue (2020-2025) & (US$ Million)
Figure 91. South Africa Acitretin Revenue (2020-2025) & (US$ Million)
Figure 92. Acitretin Industry Chain Mapping
Figure 93. Regional Acitretin Manufacturing Base Distribution (%)
Figure 94. Acitretin Production Process
Figure 95. Regional Acitretin Production Cost Structure
Figure 96. Channels of Distribution (Direct Vs Distribution)
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Acitretin market?
The top companies in the global Acitretin market are Biophore、Solara、Sun Pharma.
Related Reports
Acitretin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acitretin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 132
USD 3950.00
(Single User License)
Global Acitretin Market Research Report 2026
The global Acitretin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 133
USD 2900.00
(Single User License)
Global Acitretin Market Research Report 2025
The global market for Acitretin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 95
USD 2900.00
(Single User License)
Acitretin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acitretin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 97
USD 3950.00
(Single User License)
Global Acitretin Market Insights, Forecast to 2030
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published Date: 2024-04-16
Pages: 90
USD 4900.00
(Single User License)
Acitretin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published Date: 2024-02-21
Pages: 97
USD 3950.00
(Single User License)
Global Acitretin Market Research Report 2024
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published Date: 2024-01-08
Pages: 86
USD 2900.00
(Single User License)
Acitretin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Acitretin was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 132
USD 3950.00 (Single User License)Global Acitretin Market Research Report 2026
The global Acitretin market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 133
USD 2900.00 (Single User License)Global Acitretin Market Research Report 2025
The global market for Acitretin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 95
USD 2900.00 (Single User License)Acitretin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Acitretin was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 97
USD 3950.00 (Single User License)Global Acitretin Market Insights, Forecast to 2030
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published: 2024-04-16
Pages: 90
USD 4900.00 (Single User License)Acitretin - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published: 2024-02-21
Pages: 97
USD 3950.00 (Single User License)Global Acitretin Market Research Report 2024
Acitretin is an oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Published: 2024-01-08
Pages: 86
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now